Abstract

Highlights Developed a data preprocessing strategy to cope with missing values and mask effects in data analysis from high variation of abundant metabolites.A new method- ‘x-VAST’ was developed to amend the measurement deviation enlargement.Applying the above strategy, several low abundant masked differential metabolites were rescued.Metabolomics is a booming research field. Its success highly relies on the discovery of differential metabolites by comparing different data sets (for example, patients vs. controls). One of the challenges is that differences of the low abundant metabolites between groups are often masked by the high variation of abundant metabolites. In order to solve this challenge, a novel data preprocessing strategy consisting of three steps was proposed in this study. In step 1, a ‘modified 80%’ rule was used to reduce effect of missing values; in step 2, unit-variance and Pareto scaling methods were used to reduce the mask effect from the abundant metabolites. In step 3, in order to fix the adverse effect of scaling, stability information of the variables deduced from intensity information and the class information, was used to assign suitable weights to the variables. When applying to an LC/MS based metabolomics dataset from chronic hepatitis B patients study and two simulated datasets, the mask effect was found to be partially eliminated and several new low abundant differential metabolites were rescued.

Highlights

  • We have developed a novel data preprocessing strategy to cope with the missing values and eliminate mask effects in data analysis from high variation of abundant metabolites

  • PLASMA SAMPLES AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (HPLC-MS) ANALYSIS Thirty seven chronic hepatitis B patients hospitalized for acute deterioration in liver function and 50 healthy individuals were enrolled in this study

  • The data preprocessing is a critical step in information mining of metabolomics studies, it directly influences the discovery of differential biomarkers

Read more

Summary

Introduction

Metabolomics has been successfully applied in many fields including clinical research (Brindle et al, 2002; Yang et al, 2004, 2005; Abate-Shen and Shen, 2009; Sreekumar et al, 2009), drug discovery (Kell and Goodacre, 2014), toxicology (Keun, 2006; van Ravenzwaay et al, 2014), and phytochemistry (Fiehn, 2002; Mari et al, 2013). A general strategy of data (pre-) processing and validation for human metabolomics studies was given by Bijlsma et al (2006). They didn’t describe how the data preprocessing method affects the results and what data preprocessing methods are to be selected for a given study

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.